Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Gadicke Ansbert
Relationship:   10% Owner
City:   Boston
State:   MA
   
Insider Summary:
  
   
Companies Owned :   15    
Direct Shares   30,197    

Indirect Shares

  56,162,356      
Direct Value   $24,046    

Indirect Value

  $178,507,237      
Total Shares   56,192,553      
Total Value   $178,531,282      


Allovir Inc
 $24,046 Allovir Inc
 $24,046
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    0   
    1    

     Stock price went up :

    0   
    0    
     Stock price went down :
    0   
    1    
   
     Gain/Loss Ratio :
   0.0   
   -1.0   
     Percentage Gain/Loss :
     0.0%
 -18.7%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Rigel Pharmaceuticals Inc RIGL Former 10% Owner 2004-07-02 0 2004-09-13 475,026    Premium*  
            Idenix Pharmaceuticals Inc IDIX Director, 10% Owner 2004-07-27 0 2004-07-27 4,797,991    Premium*  
            Radius Health Inc. RDUS Director 0 2016-09-27 3,887,502    Premium*  
            Pacira Pharmaceuticals, Inc. PCRX Former 10% Owner 0 2013-03-11 2,790,479    Premium*  
            Verastem, Inc. VSTM Director 2012-02-01 0 2012-02-01 3,740    Premium*  
            Somaxon Pharmaceuticals, Inc. SOMX 10% Owner 2012-06-05 0 2012-07-09 1,275,886    Premium*  
            Epizyme, Inc. EPZM 10% Owner 0 2014-02-10 2,413,819    Premium*  
            Aratana Therapeutics, Inc. PETX 10% Owner 2014-03-07 0 2014-03-07 3,388,165    Premium*  
            Chiasma, Inc CHMA Director, 10% Owner 2015-07-21 0 2015-07-21 5,681,544    Premium*  
            Harpoon Therapeutics, Inc. HARP 10% Owner 2019-02-12 0 2019-02-12 8,422,847    Premium*  
            Tcr2 Therapeutics Inc. TCRR Director, 10% Owner 2019-02-19 0 2023-06-01 0    Premium*  
            Repare Therapeutics Inc. RPTX 10% Owner 2020-06-23 0 2021-07-12 3,882,485    Premium*  
            Allovir Inc ALVR Director, 10% Owner 2022-07-28 30,197 2022-07-28 16,674,766    Premium*  
            Dyne Therapeutics, Inc. DYN 10% Owner 2020-09-21 0 2020-09-21 91,081    Premium*  
            Oncorus, Inc. ONCR 10% Owner 0 2020-10-06 2,377,025    Premium*  
* Premium Members only  

Records found :    108         Free Registration Required For Full Results.    Limit: 25

Download
  Page 1 of 5
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
RIGL Rigel Pharmaceuticals Inc 10% Owner   –       –       •   2004-06-28 4 A $0.00 $0 I/I 16,203 1,849,800 -
RIGL Rigel Pharmaceuticals Inc Former 10% Owner   –       –      –    2004-09-13 4 A $0.00 $0 I/I 475,026 475,026 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2011-02-08 4/A A $0.00 $0 I/I 2,200,247 2,293,227 0 -
VSTM Verastem, Inc. Director   –       •      –    2012-02-01 4 A $0.00 $0 I/I 1,933,333 1,933,333 0 -
PCRX Pacira Pharmaceuticals, I... 10% Owner   –       –       •   2012-02-08 4 A $0.00 $0 I/I 2,200,247 2,293,227 0 -
EPZM Epizyme, Inc. 10% Owner   –       –       •   2013-06-05 4 A $0.00 $0 I/I 2,702,154 2,880,485 0 -
RDUS Radius Health Inc. Director   –       •       •   2014-06-06 4 A $0.00 $0 I/I 5,831,253 2,141,547 0 -
CHMA Chiasma, Inc Director   –       •       •   2015-07-21 4 A $0.00 $0 I/I 5,681,544 5,681,544 0 -
HARP Harpoon Therapeutics, Inc... 10% Owner   –       –       •   2019-02-12 4 A $0.00 $0 I/I 7,043,540 7,365,603 0 -
TCRR Tcr2 Therapeutics Inc. Director   –       •       •   2019-02-19 4 A $0.00 $0 I/I 5,852,612 2,704,315 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2020-06-23 4 A $0.00 $0 I/I 4,892,109 4,892,109 0 -
ALVR Allovir Inc Director   –       •       •   2020-08-03 4 A $0.00 $0 I/I 13,420,970 13,420,970 0 -
DYN Dyne Therapeutics, Inc. 10% Owner   –       –       •   2020-09-21 4 A $0.00 $0 I/I 4,951,303 91,081 0 -
ONCR Oncorus, Inc. 10% Owner   –       –       •   2020-10-06 4 A $0.00 $0 I/I 4,785,655 2,225,801 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-03-15 4 A $0.00 $0 I/I 24,271 4,672,838 0 -
ALVR Allovir Inc Director   –       •       •   2022-07-28 4 A $4.61 $15,000,000 I/I 3,253,796 16,674,766 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-18 4 AS $33.90 $799,571 I/I (23,404) 4,649,434 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-18 4 AS $0.00 $0 I/I (21,834) 4,627,600 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-19 4 AS $34.23 $466,965 I/I (13,543) 4,614,057 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-20 4 AS $34.66 $345,428 I/I (9,957) 4,604,100 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-21 4 AS $34.80 $10,532,881 I/I (302,669) 4,301,431 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-24 4 AS $33.30 $757,540 I/I (22,200) 4,279,231 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-25 4 AS $32.87 $216,094 I/I (6,572) 4,272,659 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-26 4 AS $32.74 $787,399 I/I (24,036) 4,248,623 0 -
RPTX Repare Therapeutics Inc. 10% Owner   –       –       •   2021-05-27 4 AS $32.81 $262,141 I/I (7,951) 4,240,672 0 -

  108  Records found
  1  2   3   4   5      
  Page 1 of 5  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed